Individuals with intellectual and/or developmental disabilities (I/DD) are particularly susceptible to COVID-19, demonstrating more severe illness, greater risk of hospitalization, and almost twice the case fatality rates for individuals aged 18–74[^1].
Current COVID-19 vaccines continue to exhibit strong protection against severe disease and death across all virus variants seen to date. Therefore, reaching high coverage with the primary vaccination series and additional doses among all eligible people, especially the most vulnerable including those with I/DD, remains a priority.
References:
- Source: Prioritizing COVID-19 vaccinations for individuals with intellectual and developmental disabilities - eClinicalMedicine https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00029-8/fulltext